U.S. markets close in 5 hours 31 minutes
  • S&P 500

    -39.91 (-1.05%)
  • Dow 30

    -338.99 (-1.09%)
  • Nasdaq

    -131.53 (-1.00%)
  • Russell 2000

    -36.34 (-1.69%)
  • Crude Oil

    -1.31 (-2.45%)
  • Gold

    -18.50 (-1.00%)
  • Silver

    -0.95 (-3.67%)

    -0.0063 (-0.52%)
  • 10-Yr Bond

    -0.0230 (-2.04%)

    -0.0099 (-0.72%)

    -0.0460 (-0.04%)

    -1,067.82 (-2.84%)
  • CMC Crypto 200

    -34.38 (-4.68%)
  • FTSE 100

    -100.95 (-1.48%)
  • Nikkei 225

    -179.08 (-0.62%)

Here's Why We're Not Too Worried About AVROBIO's (NASDAQ:AVRO) Cash Burn Situation

Simply Wall St
·4 min read

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?

So, the natural question for AVROBIO (NASDAQ:AVRO) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of money a company spends each year to fund its growth. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

See our latest analysis for AVROBIO

When Might AVROBIO Run Out Of Money?

A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. When AVROBIO last reported its balance sheet in June 2020, it had zero debt and cash worth US$244m. In the last year, its cash burn was US$77m. So it had a cash runway of about 3.2 years from June 2020. Notably, analysts forecast that AVROBIO will break even (at a free cash flow level) in about 3 years. So there's a very good chance it won't need more cash, when you consider the burn rate will be reducing in that period. The image below shows how its cash balance has been changing over the last few years.


How Is AVROBIO's Cash Burn Changing Over Time?

AVROBIO didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. Nonetheless, we can still examine its cash burn trajectory as part of our assessment of its cash burn situation. With the cash burn rate up 26% in the last year, it seems that the company is ratcheting up investment in the business over time. That's not necessarily a bad thing, but investors should be mindful of the fact that will shorten the cash runway. Clearly, however, the crucial factor is whether the company will grow its business going forward. So you might want to take a peek at how much the company is expected to grow in the next few years.

How Hard Would It Be For AVROBIO To Raise More Cash For Growth?

Given its cash burn trajectory, AVROBIO shareholders may wish to consider how easily it could raise more cash, despite its solid cash runway. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash and fund growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.

AVROBIO has a market capitalisation of US$607m and burnt through US$77m last year, which is 13% of the company's market value. Given that situation, it's fair to say the company wouldn't have much trouble raising more cash for growth, but shareholders would be somewhat diluted.

How Risky Is AVROBIO's Cash Burn Situation?

It may already be apparent to you that we're relatively comfortable with the way AVROBIO is burning through its cash. For example, we think its cash runway suggests that the company is on a good path. Although its increasing cash burn does give us reason for pause, the other metrics we discussed in this article form a positive picture overall. Shareholders can take heart from the fact that analysts are forecasting it will reach breakeven. Looking at all the measures in this article, together, we're not worried about its rate of cash burn; the company seems well on top of its medium-term spending needs. An in-depth examination of risks revealed 2 warning signs for AVROBIO that readers should think about before committing capital to this stock.

Of course AVROBIO may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.